MedTrace Logo

International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis

NCT02041624 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 740

Last updated 2016-04-18

No results posted yet for this study

Summary

The purpose of the present study is to describe patient's perception of quality of life and effectiveness of ORALAIR® over a follow-up period up to 5 years, in real-life settings.

Conditions

  • Allergic Rhinitis Due to Grass Pollens

Sponsors & Collaborators

  • Registrat-Mapi

    collaborator OTHER

  • Stallergenes Greer

    lead INDUSTRY

Principal Investigators

  • Alain DIDIER, MD · Hôpital Larrey, Toulouse, France

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02041624 on ClinicalTrials.gov